These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 32710713

  • 1. Phase II study of reduced-dose craniospinal irradiation and combination chemotherapy for children with newly diagnosed medulloblastoma: A report from the Japanese Pediatric Brain Tumor Consortium.
    Okada K, Soejima T, Sakamoto H, Hirato J, Hara J.
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28572. PubMed ID: 32710713
    [Abstract] [Full Text] [Related]

  • 2. Strategy to minimize radiation burden in infants and high-risk medulloblastoma using intrathecal methotrexate and high-dose chemotherapy: A prospective registry study in Japan.
    Yamasaki K, Okada K, Soejima T, Sakamoto H, Hara J.
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28012. PubMed ID: 31544362
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study.
    Wahba HA, Abu-Hegazy M, Wasel Y, Ismail EI, Zidan AS.
    J BUON; 2013 Jan; 18(2):425-9. PubMed ID: 23818356
    [Abstract] [Full Text] [Related]

  • 4. Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.
    Sung KW, Lim DH, Son MH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.
    Neuro Oncol; 2013 Mar; 15(3):352-9. PubMed ID: 23258845
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE, Kun LE, Krasin MJ, Wallace D, Chintagumpala MM, Woo SY, Ashley DM, Sexton M, Kellie SJ, Ahern V, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):782-7. PubMed ID: 17892918
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 9. Reduced-dose craniospinal irradiation is feasible for standard-risk adult medulloblastoma patients.
    Massimino M, Sunyach MP, Barretta F, Gandola L, Garegnani A, Pecori E, Spreafico F, Bonneville-Levard A, Meyronet D, Mottolese C, Boschetti L, Biassoni V, Schiavello E, Giussani C, Carrabba G, Diletto B, Pallotti F, Stefini R, Ferrari A, Terenziani M, Casanova M, Luksch R, Meazza C, Podda M, Chiaravalli S, Puma N, Bergamaschi L, Morosi C, Calareso G, Giangaspero F, Antonelli M, Buttarelli FR, Frappaz D.
    J Neurooncol; 2020 Jul 01; 148(3):619-628. PubMed ID: 32567042
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
    Atalar B, Ozsahin M, Call J, Napieralska A, Kamer S, Villa S, Erpolat P, Negretti L, Lassen-Ramshad Y, Onal C, Akyurek S, Ugurluer G, Baumert BG, Servagi-Vernat S, Miller RC, Ozyar E, Sio TT.
    Radiother Oncol; 2018 Apr 01; 127(1):96-102. PubMed ID: 29373196
    [Abstract] [Full Text] [Related]

  • 13. Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.
    Lee JW, Lim DH, Sung KW, Cho HW, Ju HY, Hyun JK, Yoo KH, Koo HH, Suh YL, Joung YS, Shin HJ.
    Cancer Med; 2020 Aug 01; 9(16):5807-5818. PubMed ID: 32608158
    [Abstract] [Full Text] [Related]

  • 14. A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
    Allen J, Donahue B, Mehta M, Miller DC, Rorke LB, Jakacki R, Robertson P, Sposto R, Holmes E, Vezina G, Muraszko K, Puccetti D, Prados M, Chan KW.
    Int J Radiat Oncol Biol Phys; 2009 Jul 15; 74(4):1006-11. PubMed ID: 19356859
    [Abstract] [Full Text] [Related]

  • 15. High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor.
    Sung KW, Yoo KH, Cho EJ, Koo HH, Lim DH, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT.
    Pediatr Blood Cancer; 2007 Apr 15; 48(4):408-15. PubMed ID: 17066462
    [Abstract] [Full Text] [Related]

  • 16. Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study.
    Strother D, Ashley D, Kellie SJ, Patel A, Jones-Wallace D, Thompson S, Heideman R, Benaim E, Krance R, Bowman L, Gajjar A.
    J Clin Oncol; 2001 May 15; 19(10):2696-704. PubMed ID: 11352962
    [Abstract] [Full Text] [Related]

  • 17. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
    Murphy ES, Merchant TE, Wu S, Xiong X, Lukose R, Wright KD, Qaddoumi I, Armstrong GT, Broniscer A, Gajjar A.
    Int J Radiat Oncol Biol Phys; 2012 Aug 01; 83(5):e655-60. PubMed ID: 22768993
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.